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A recently proposed single progenitor cell model for skin cell proliferation [Clayton et al., Nature
446, 185 (2007)] is extended to incorporate homeostasis as a fixed point of the dynamics. Unlimited
cell proliferation in such a model can be viewed as a paradigm for the onset of cancer. A novel
way in which this can arise is if the homeostatic fixed point becomes metastable, so that the cell
populations can escape from the homeostatic basin of attraction by a large but rare stochastic
fluctuation. Such an event can be viewed as the final step in a multi-stage model of carcinogenesis.
This offers a possible explanation for the peculiar epidemiology of lung cancer in ex-smokers.
PACS numbers: 87.17.Ee, 87.18.Tt, 87.19.xj
The epidermis is the outermost part of the skin barrier.
It comprises 10–20 layers of skin cells, which are predom-
inantly keratinocytes [1]. Keratinocytes proliferate in the
basal layer, move up through the middle layers, and are
finally shed from the outermost layer at a desquamation
rate of the order 103 cells hr−1mm−2 [2]. This process
means that cells have to proliferate continuously in the
basal layer to replenish the supra-basal layers. Faulty cell
proliferation in the basal layer has important health-care
consequences, for example basal cell carcinoma is one of
the most prevalent forms of cancer [3].
Motivated by elegant in vivo experiments on labelled
keratinocyte clones, Clayton et al. [4, 5, 6] recently pro-
posed a novel single progenitor cell (SPC) model for basal
layer proliferation. In the present paper I examine an ex-
tension of this SPC model to include autoregulation, and
homeostasis as a dynamical fixed point. Interestingly,
something resembling the onset of cancer (i. e. carcino-
genesis) arises naturally in the new model if the homeo-
static fixed point loses stability in the direction of unlim-
ited growth of the cell populations. One intriguing possi-
bility is ‘homeostatic metastability’, in which a large but
rare stochastic fluctuation results in the cell populations
escaping from the homeostatic basin of attraction. Such
a rare escape event can be viewed as the final step in a
multi-stage model of carcinogenesis [7, 8].
In the SPC model, there are two cell types, or ‘com-
partments’: progenitor cells A, and post-mitotic cells B.
These proliferate according to
A→ A+A rate λ1, A→ A+ B rate λ2,
A→ B+ B rate λ3, B→ ∅ rate Γ.
(1)
The first three processes represent possible progenitor
cell division pathways. The last process represents post-
mitotic cells leaving the basal layer. Obviously, the pro-
genitor cell division pathways must be finely balanced
otherwise the cell populations either grow or vanish ex-
ponentially [9]. Making the assumption therefore that
λ1 = λ3, Clayton et al. [4, 5] write λ1 = λ3 = λr and
λ2 = λ(1−2r). For mouse skin, they find λ ≈ 0.16 day
−1
for the overall progenitor cell division rate, and 2r ≈ 0.16
for the branching ratio into the symmetric division path-
ways (in later work 2r ≈ 0.4 [6] but the actual value is
not too important). A steady state condition for the cell
populations is
λρ = Γ(1− ρ) (2)
where ρ = nA/n ≈ 0.22 is the fraction of progenitor cells,
n = nA+nB is the total cell density, and nA and nB are
the individual cell densities. From this one determines
Γ ≈ 0.045 day−1, compatible with the above-mentioned
desquamation rate.
A phase space portrait and a representative stochastic
trajectory for the SPC model are shown in Fig. 1(a). The
trajectory was generated using a standard kinetic Monte-
Carlo algorithm [10], starting from a patch of area A
comprising initially N = An = 200 cells, and assuming
the cell types remain well-mixed. The actual value of A
is irrelevant since the processes in Eq. (1) are all first
order. In Fig. 1, the ordinate is n/n0 ≡ N/N0 where n0
(N0) is the initial cell density (number).
Whilst providing an eminently satisfactory explana-
tion for the keratinocyte labelling data, the original SPC
model includes a fine-tuning assumption, λ1 = λ3, mak-
ing it structurally unstable in the language of dynam-
ical systems theory [11]. As a consequence the model
lacks homeostasis in the sense that it possesses a line
of stable fixed points, shown in Fig. 1(a). Also it is
not generally robust against perturbations, for exam-
ple it cannot accommodate the introduction of a small
population of stem cells [12], without making some ad-
ditional fine-tuning assumptions. One obvious solution
to this is to suppose that the cell division rates depend
on the cell population densities nA and nB, representing
the fact that cellular fates are governed by integration
of autocrine and paracrine signalling factors [12, 13, 14];
indeed this idea was already suggested by Jones and Si-
mon as an avenue for further investigation [15]. In such
an autoregulating SPC (ASPC) model, the fine-tuning
would arise as a consequence of the cell population dy-
2namics driving the system to a homeostatic fixed point.
An ASPC model would be structurally stable from the
point of view of dynamical systems theory, and also able
to withstand perturbations, such as the presence of a
small number of stem cells.
To develop such an ASPC model, I start by introducing
a control parameter q to describe a possible bias in the
symmetric cell division fates, thus
λ1 = λr(1− q), λ2 = λ(1− 2r), λ3 = λr(1 + q). (3)
The parameters λ, r and q replace λ1, λ2 and λ3 without
loss of generality. The steady state conditions are given
by q = 0 and Eq. (2). From this point onwards, I delib-
erately adopt a ‘physics-oriented’ approach in which the
model is kept as simple as possible to expose the general
mechanisms at work. In particular it is not claimed that
the biology is accurately represented. The basic idea is to
introduce a minimalist dependence of q and λ on the cell
population densities, to represent the integrated effect
of the intercellular signals. I start by making q = q(ρ).
Then the steady state condition selects the value of ρ for
which q(ρ) = 0. I additionally suppose that λ = λ(n) is a
decreasing function of the total number density (λ′ < 0)
representing the fact that the progenitor cell proliferation
rate should be reduced if the overall cell density increases
[16]. With these assumptions, fixed points of the dynam-
ics are determined by q(ρ) = 0 and λ(n) = Γ(1−ρ)/ρ. It
is a straightforward exercise to show, in the language of
dynamical systems theory, that a fixed point is a stable
node if q′ > 0, and a saddle if q′ < 0.
A concrete model of this type has
λ = λ0
(n0
n
)α
, q = tanh
[βρ0(1 − ρ0)(ρ− ρ0)
ρ(1 − ρ)
]
, (4)
where λ0 = Γ(1− ρ0)/ρ0. This model has a stable node
at a target population density n = n0 and progenitor cell
fraction ρ = ρ0. I emphasise that these functions have
been arbitrarily chosen for illustrative purposes, though
with care to make sure that they have the appropriate
limiting behaviours. In Eq. (4) α and β are ‘stiffness’
coefficients. They are related to derivatives of the func-
tions at the fixed point by α = −nλ′/λ and β = q′. For
results presented below I use α = 2 and β = 10 which
allows for stochastic fluctuations of moderate amplitude,
balanced between the two cell types. I have checked that
the results are qualitatively insensitive to this choice.
Fig. 1(b) shows the phase space portrait and a repre-
sentative stochastic trajectory for this ASPC model with
a fixed point chosen to lie at ρ0 = 0.22 and a target popu-
lation size N0 = An0 = 200. AgainA does not need to be
explicitly specified though in this case it could be inter-
preted as representing the area of influence of diffusible
intercellular signalling factors. In contrast to Fig. 1(a),
there is an isolated stable fixed point, whose basin of at-
traction extends to cover the whole plane. The stochastic
trajectory is strongly localised to the vicinity of the fixed
point. It is clear that this behaviour should be generic
to a wide class of ASPC models since the existence of an
isolated stable fixed point is a structurally stable feature
of the dynamics. The fixed point in a model of this type
represents homeostasis in several ways. Firstly, if the
cell populations are perturbed, they will tend to return
to the original fixed point. Secondly, fluctuations in the
cell populations will be limited to the vicinity of the fixed
point. Thirdly, the model itself can be perturbed, for ex-
ample by the inclusion of stem cells, without leading to
a qualitative change in behaviour.
A key requirement of such models is that they re-
tain compatibility with the keratinocyte labelling data
of Clayton et al. [4, 5]. An (admittedly mean-field) argu-
ment that this is true can be made as follows. Imagine
labelling a small fraction of keratinocytes. If the label is
passive, proliferation of labelled cells will be determined
by fixed parameter values, corresponding to the homeo-
static fixed point. In particular the symmetric division
pathways of labelled progenitor cells will be automati-
cally balanced.
I now turn to the implications for cancer modelling.
As outlined in the introduction, the ASPC models might
offer some interesting insights into carcinogenesis, which
can be considered as unlimited cell proliferation caused
either by a loss of stability of the homeostatic fixed
point, or by a large but rare stochastic fluctuation caus-
ing the system to exit the homeostatic basin of attrac-
tion. Whilst the idea that cancer arises from an instabil-
ity in the underlying cell population dynamics is rather
old [13, 17], the second possibility is very intriguing and
has apparently not been hitherto considered. My studies
of models comprising A, A∗ and B cells, with a pro-
cess A→ A∗ representing a somatic mutation (c. f. Klein
et al. [5]), shows that the phenomenon of ‘homeostatic
metastability’ can easily be observed. However the re-
sulting three-dimensional phase space portraits are tricky
to represent and analyse. To illustrate the mechanism of
homeostatic metastability therefore, I return to the origi-
nal ASPC model, but introduce a re-entrant bias control
function q(ρ). Such a model is a prototypical example of
a system which is near a saddle-node bifurcation.
An example of a re-entrant q(ρ) is given by inserting
an extra factor (ρ1− ρ)/(ρ1− ρ0) in the argument to the
tanh function in Eq. (4). This model has a stable node at
ρ = ρ0 and a saddle at ρ = ρ1. The saddle-node bifurca-
tion is approached as ∆ρ = ρ1 − ρ0 vanishes. The phase
space portrait and a representative stochastic trajectory
for this ASPC model are shown in Fig. 1(c) for ∆ρ = 0.04
(other parameters as for the original ASPC model). The
homeostatic basin of attraction is now confined to the
lower left region. The saddle lies on the homeostatic
basin boundary. The simulations show that the system
inevitably escapes from the homeostatic basin, typically
in the vicinity of the saddle. After this the cell popula-
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FIG. 1: (color online). Phase space portraits for (a) the SPC
model, (b) an autoregulating SPC (ASPC) model, and (c) an
ASPC model exhibiting homeostatic metastability. The axes
are the progenitor cell fraction, ρ, and the ratio between the
current and initial total cell densities, n/n0. Thin black lines
are phase space flows, with the direction indicated by the ar-
rows. In (a) the thick blue line is the line of fixed points of the
SPC model. In (b) and (c) the filled blue circles are homeo-
static stable fixed points (nodes). In (c) the open blue circle
is an unstable fixed point (a saddle), lying on the homeostatic
basin boundary shown as a dashed blue line. Jagged red lines
are representative stochastic trajectories.
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FIG. 2: (color online). Data collapse of homeostatic escape
rate u as a function of N0∆ρ
2. Data were collected for various
N0 and (colored) for ∆ρ = 0.030(0.005)0.055.
tions grow without limit.
To characterise the escape event, I generate a large set
of trajectories and compute an escape rate u from the
probability of remaining in the homeostatic basin [18].
Fig. 2 shows that u decreases approximately exponen-
tially with N0∆ρ
2 [19]. The sensitive dependence on the
target population size N0 is reminiscent of system size
effects found for other non-equilibrium phase transitions
[20]. The sensitivity to the distance ∆ρ from the saddle-
node bifurcation may reflect a quadratic dependence of
the height of an ‘action’ barrier [21].
The concept of homeostatic metastability fits neatly
into multi-stage models which are widely used to inter-
pret cancer epidemiology [7, 8]. In a multi-stage model,
cell lineages slowly transit through one or more pre-
cancerous stages before entering a final cancerous stage.
The idea presented here is that homeostatic escape could
be the final slow step after one or more somatic muta-
tions have taken place, bringing, for instance, the system
close to a saddle-node bifurcation. Note that, extrapo-
lating from Fig. 2, the homeostatic escape rate can easily
be comparable to multi-stage transition rates which are
of the order 10−6–10−4 yr−1 [22]. In this context it is
intriguing to note that the initial step in the develop-
ment of skin cancer often appears to involve a mutation
in the ras signalling pathway [23], which is important for
controlling cell proliferation.
The mechanism of epithelial renewal in the lungs has
much in common with that of the skin, although the
turnover time may be somewhat longer [24]. Lung can-
cer might therefore be expected to have many features
in common with skin cancer. A long-standing puzzle in
multi-stage models of lung cancer has been the apparent
indifference of the rate of the final step to the presence
of a carcinogen (tobacco smoke) [25, 26, 27]. This epi-
demiology has been interpreted as indicating that a non-
4mutagenic mechanism might be at work. One suggestion
is that the final step is epigenetic in nature [26]. An-
other suggestion is that the final step somehow involves
signalling [27]. Homeostatic metastability can be seen as
a specific example of the latter signalling mechanism. As
Frank challenges though [8], any such interpretation of
the epidemiology should be supported by other evidence.
Experiments that directly test the mechanism of homeo-
static escape are therefore very desirable! A central fea-
ture of the present model, around which experiments may
perhaps be designed, is that the cells themselves do not
undergo any change if the system escapes from home-
ostasis; only the micro-environment changes.
Some general points can be made about directions for
future research. Firstly, many of the arguments presented
here are mean-field in nature. This key point was well
appreciated by Klein et al. [6], who showed that many
mean-field results still hold in a two-dimensional version
of the original SPC model. The extension of the present
ASPC models to fully-fledged two dimensional models is
clearly a crucial next step. Another direction in which
progress could be made is to improve the representation
of the biology, for example moving to multi-scale [28],
or agent-based models [29], which capture the detailed
biology of the intercellular signals, and also the essential
stochastic nature of individual cell fates.
A generic conclusion of the present study is that it
may not be valid to examine just the deterministic conse-
quences of somatic mutations, since rare stochastic events
may occur at comparable rates. This makes the task
of examining the behaviour of more biologically detailed
models rather formidable. Brute force methods (i. e. lots
of very long simulations) have been used in the present
paper since the underlying stochastic processes are rather
simple. This may not be possible for more complex mod-
els. Instead, it may be necessary to bring to bear more
sophisticated techniques such as transition path sampling
[30], or forward-flux sampling [31].
I thank Rosalind Allen, Mike Cates and Martin Evans
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